coronavirus
cov
caus
outbreak
deadli
pneumonia
human
sinc
begin
centuri
sever
acut
respiratori
syndrom
coronaviru
sarscov
emerg
respons
epidem
spread
five
contin
fatal
rate
contain
addit
case
report
middleeast
respiratori
syndrom
coronaviru
merscov
emerg
arabian
peninsula
caus
recurr
outbreak
human
fatal
rate
sarscov
merscov
zoonot
virus
cross
speci
barrier
use
batspalm
civet
dromedari
camel
respect
specif
treatment
vaccin
approv
six
human
coronavirus
highlight
need
investig
principl
govern
viral
entri
crossspeci
transmiss
well
prepar
zoonot
outbreak
like
occur
due
larg
reservoir
cov
found
mammal
bird
review
understand
infect
mechan
use
coronavirus
deriv
recent
structur
biochem
studi
three
dimension
angiotensinconvert
enzym
apn
aminopeptidas
n
cov
coronaviru
cryoem
cryoelectron
microscopi
dipeptidyl
peptidas
fab
antigenbind
fragment
antibodi
merscov
middleeast
respiratori
syndrom
coronaviru
mhv
mous
hepat
viru
pdcov
porcin
pedv
porcin
epidem
diarrhea
viru
sarscov
sever
acut
respiratori
syndrom
coronaviru
tgev
transmiss
gastroenter
viru
coronavirus
cov
envelop
virus
posit
sens
rna
genom
belong
subfamili
coronavirina
within
famili
coronavirida
part
nidoviral
order
classifi
four
genera
four
lineag
recogn
whithin
genu
b
c
cov
caus
varieti
respiratori
enter
diseas
mammalian
avian
speci
recent
cov
consid
pathogen
larg
veterinari
relev
limit
impact
human
health
howev
outbreak
sever
acut
respiratori
syndrom
sar
middleeast
respiratori
syndrom
mer
start
fatal
rate
respect
led
cov
recogn
zoonot
threat
pandem
potenti
four
cov
endem
human
popul
caus
mild
respiratori
tract
infect
well
occasion
sever
diseas
young
children
elderli
immunocompromis
individu
isaac
et
al
su
et
al
virus
well
numer
sarscov
merscovlik
virus
current
circul
bat
dromedari
make
outbreak
highli
pathogen
human
cov
global
health
threat
ge
et
al
haagman
et
al
hu
et
al
menacheri
et
al
menacheri
et
al
sabir
et
al
cov
virion
contain
least
four
structur
protein
spike
envelop
e
membran
nucleocapsid
n
contrast
lineag
lineag
cov
also
encod
hemagglutininesteras
serv
receptordestroy
enzym
facilit
releas
viral
progeni
infect
cell
escap
attach
nonpermiss
host
cell
decoy
bakker
et
al
bakker
et
al
class
viral
fusion
protein
promot
host
attach
fusion
viral
cellular
membran
entri
bosch
et
al
consequ
determin
host
rang
cell
tropism
also
main
target
neutral
antibodi
elicit
infect
focu
vaccin
design
trimer
protom
synthes
singl
polypeptid
chain
residu
depend
cov
speci
mani
cov
process
host
proteas
gener
two
function
subunit
design
remain
noncoval
bound
prefus
conform
bosch
et
al
subunit
compris
apex
trimer
includ
receptorbind
domain
stabil
prefus
state
fusion
machineri
anchor
viral
membran
cov
cleav
host
proteas
socal
site
locat
immedi
upstream
fusion
peptid
cleavag
propos
activ
protein
membran
fusion
via
largescal
irrevers
conform
chang
healdsarg
gallagh
millet
whittak
although
sever
class
viral
fusion
protein
extens
studi
cov
protein
proven
reluct
structur
character
recent
structur
studi
larg
limit
xray
crystallograph
analysi
isol
receptorbind
domain
complex
viral
receptor
ectodomain
neutral
antibodi
li
et
al
lu
et
al
peng
et
al
prabakaran
et
al
reguera
et
al
wang
et
al
wong
et
al
wu
et
al
yu
et
al
postfus
core
duquerroy
et
al
gao
et
al
supekar
et
al
xu
et
al
b
zheng
et
al
except
two
lowresolut
electron
microscopi
report
beniac
et
al
beniac
et
al
past
year
howev
technic
advanc
singleparticl
cryoelectron
microscopi
cryoem
bai
et
al
brilot
et
al
campbel
et
al
campbel
et
al
li
et
al
punjani
et
al
schere
togeth
implement
strategi
stabil
cov
protein
prefus
conform
pallesen
et
al
wall
et
al
led
surg
structur
data
multipl
ectodomain
trimer
review
current
understand
mechan
use
cov
infect
host
cell
base
recent
structur
biochem
studi
glycoprotein
ectodomain
prefus
postfus
state
well
complex
known
receptor
neutral
antibodi
cryoem
studi
glycoprotein
mous
hepat
viru
mhv
led
first
structur
highenough
resolut
obtain
atom
model
prefus
state
kirchdoerf
et
al
wall
et
al
structur
reveal
prefus
ectodomain
long
trimer
triangular
crosssect
fig
b
subunit
adopt
v
shape
architectur
cov
gui
et
al
kirchdoerf
et
al
shang
et
al
tortorici
et
al
wall
et
al
yuan
et
al
fig
squareshap
organ
shang
et
al
wall
et
al
xiong
et
al
subunit
fold
domain
design
b
c
sever
harbor
like
duplic
domain
nterminu
glycoprotein
wall
et
al
addit
domain
design
domain
visual
structur
hypothes
interact
heparan
sulfat
present
host
cell
surfac
viral
entri
milewska
et
al
wall
et
al
domain
domain
adopt
galectinlik
fold
conserv
across
cov
genera
kirchdoerf
et
al
peng
et
al
peng
et
al
wall
et
al
fig
domain
b
show
highest
sequenc
variabl
within
cov
subunit
markedli
differ
architectur
b
domain
contain
core
subdomain
decor
highli
variabl
extern
subdomain
mediat
receptor
engag
kirchdoerf
et
al
li
et
al
lu
et
al
tortorici
et
al
wall
et
al
wang
et
al
fig
b
domain
form
decor
loop
mediat
receptor
attach
reguera
et
al
shang
et
al
b
wall
et
al
wong
et
al
xiong
et
al
context
trimer
cov
b
domain
interact
b
domain
anoth
protom
wherea
pack
domain
protom
shang
et
al
wall
et
al
b
xiong
et
al
subunit
conserv
compris
fusion
machineri
connect
viral
membran
assembl
larg
number
antiparallel
core
connector
domain
stem
helix
lead
heptadrepeat
transmembran
region
fig
gui
et
al
kirchdoerf
et
al
kirchdoerf
et
al
pallesen
et
al
shang
et
al
b
tortorici
et
al
wall
et
al
wall
et
al
b
xiong
et
al
yuan
et
al
key
featur
facilit
viruscel
fusion
includ
fusion
peptid
two
heptad
repeat
region
name
transmembran
domain
prefus
conform
central
helix
stretch
along
threefold
axi
perpendicular
viral
membran
locat
downstream
motif
fold
four
consecut
kirchdoerf
et
al
wall
et
al
moreov
upstream
helix
run
parallel
zip
central
helix
via
hydrophob
contact
fig
cov
subunit
share
similar
pneumovirusparamyxoviru
f
proteinsinclud
compar
organ
core
upstream
helix
central
helixsuggest
evolutionari
related
viral
fusion
protein
differ
virus
conserv
fusion
mechan
mclellan
et
al
wall
et
al
wall
et
al
wong
et
al
xu
et
al
yin
et
al
conserv
tryptophanrich
segment
vi
kwpw
yw
vwl
directli
preced
cov
transmembran
region
crucial
proper
trimer
segment
also
requir
function
format
fusion
pore
schrothdiez
et
al
furthermor
transmembran
domain
interact
within
possibl
trimer
propos
essenti
complet
membran
fusion
process
schrothdiez
et
al
transmembran
domain
follow
intraviralcytoplasm
tail
variabl
length
residu
depend
coronaviru
speci
contain
palmitoyl
cysteinerich
region
residu
cystein
variabl
ctermin
end
thorp
et
al
cytoplasm
tail
involv
assembl
intracellular
transport
cellsurfac
express
cellcel
fusion
bo
et
al
bosch
et
al
chang
et
al
lontok
et
al
petit
et
al
ye
et
al
youn
et
al
current
structur
inform
avail
cov
fulllength
hinder
understand
influenc
transmembran
cytoplasm
domain
conform
expos
antigen
site
previous
studi
envelop
chen
et
al
dev
et
al
cov
entri
suscept
cell
complex
process
requir
concert
action
receptorbind
proteolyt
process
protein
promot
viruscel
fusion
healdsarg
gallagh
millet
whittak
domain
domain
andor
domain
b
act
receptorbind
domain
attach
entri
receptor
describ
depend
cov
speci
lineag
attach
via
domain
found
glycoprotein
glycolipid
host
cell
surfac
promot
entri
suscept
cell
vlasak
et
al
includ
human
cov
bovin
cov
bcov
porcin
hemagglutin
encephalomyel
viru
recent
identifi
visual
cryoem
sialosidebind
site
locat
groov
surfac
domain
fig
hulswit
et
al
tortorici
et
al
site
conserv
cov
known
attach
lineag
share
architectur
similar
ligandbind
pocket
cov
hemagglutininesteras
influenza
viru
cd
hemagglutininesterasefus
glycoprotein
highlight
common
structur
principl
recognit
bakker
et
al
bakker
et
al
hulswit
et
al
rosenth
et
al
tortorici
et
al
current
consensu
field
util
host
receptor
line
statement
ligandinteract
residu
shown
essenti
smediat
viral
entri
hulswit
et
al
tortorici
et
al
deplet
target
cell
result
sever
decreas
viru
infect
krempl
et
al
vlasak
et
al
free
howev
trigger
conform
chang
associ
membran
fusion
observ
contrast
data
sarscov
addit
human
angiotensinconvert
enzym
ectodomain
proteinac
receptor
promot
refold
postfus
state
song
et
al
wall
et
al
find
suggest
either
receptor
differ
proteinac
receptor
mode
action
interact
yet
unidentifi
proteinac
receptor
requir
viru
intern
entri
target
cell
sialosidebind
site
identifi
conserv
among
cov
also
known
interact
sialoglycan
initi
host
cell
infect
outsid
lineag
merscov
lineag
c
infecti
bronchiti
viru
ibv
wickramasingh
et
al
transmiss
gastroenter
viru
tgev
porcin
epidem
diarrhea
viru
pedv
use
domain
attach
sialoglycan
presum
increas
viru
concentr
cell
surfac
enhanc
subsequ
attach
proteinac
receptor
schwegmannwessel
et
al
carbohydr
bind
via
domain
propos
determin
tgev
enter
tropism
sinc
loss
domain
appear
correl
loss
enter
tropism
porcin
respiratori
coronaviru
prcov
latter
viru
natur
occur
tgev
variant
krempl
et
al
cov
exploit
limit
varieti
proteinac
receptor
compar
larg
number
divers
viral
speci
cov
known
engag
proteinac
receptor
use
domain
b
except
mhv
bind
use
domain
dveksler
et
al
peng
et
al
william
et
al
remark
virus
differ
genera
sarscov
recogn
region
entri
receptor
use
structur
distinct
b
domain
hofmann
et
al
li
et
al
li
et
al
wu
et
al
mani
includ
tgev
prcv
well
porcin
pdcov
util
aminopeptidas
n
apn
entri
receptor
delma
et
al
delma
et
al
li
et
al
reguera
et
al
wong
et
al
yeager
et
al
wherea
merscov
use
dipeptidyl
peptidas
raj
et
al
wang
et
al
crystal
structur
sarscov
merscov
b
domain
complex
cognat
receptor
provid
atom
detail
interactinginterfac
identifi
key
residu
crossspeci
transmiss
infect
fig
li
et
al
lu
et
al
wang
et
al
wong
et
al
wu
et
al
inform
use
guid
develop
therapeut
vaccin
human
cov
recent
cryoem
studi
reveal
merscov
sarscov
adopt
open
close
conform
receptor
bind
site
domain
b
expos
occlud
respect
gui
et
al
kirchdoerf
et
al
pallesen
et
al
song
et
al
wall
et
al
yuan
et
al
contrast
mhv
pdcov
ibv
glycoprotein
appear
adopt
close
conform
kirchdoerf
et
al
shang
et
al
b
tortorici
et
al
wall
et
al
b
xiong
et
al
unknown
trigger
besid
proteolyt
activ
might
necessari
virus
expos
receptorbind
motif
recognit
occur
find
suggest
cov
evolv
finetun
mechan
balanc
mask
receptorbind
motif
put
avoid
neutral
host
humor
immun
respons
necessari
exposur
enabl
receptor
recognit
infect
host
cell
wall
et
al
wong
et
al
upon
host
recognit
cov
intern
via
receptormedi
clathrindepend
caveolindepend
uptak
pathway
burkard
et
al
eifart
et
al
inou
et
al
nomura
et
al
instanc
clathrindepend
clathrincaveolaeindepend
entri
pathway
report
sarscov
inou
et
al
wang
et
al
felin
infecti
periton
viru
suggest
enter
host
cell
via
clathrincaveolinindepend
intern
rout
regan
et
al
van
hamm
et
al
wherea
caveolindepend
endocyt
uptak
suggest
nomura
et
al
owczarek
et
al
sever
report
demonstr
key
role
proteolyt
process
cov
cellcel
fusion
activ
andor
viru
entri
host
cell
use
experi
inhibit
intracellular
proteas
burkard
et
al
frana
et
al
simmon
et
al
yamada
liu
andor
substitut
residu
cleavag
site
belouzard
et
al
millet
whittak
wicht
et
al
yang
et
al
prior
andor
uptak
virion
host
cell
protein
proteolyt
process
host
proteas
one
two
cleavag
site
receptorbind
proteolyt
process
act
synergi
induc
largescal
conform
chang
promot
cov
entri
one
cleavag
site
locat
boundari
subunit
cleavag
site
wherea
locat
immedi
upstream
fusion
peptid
cleavag
site
review
millet
whittak
cleavag
site
occur
upon
viral
egress
mhv
frana
et
al
upon
encount
target
cell
sarscov
belouzard
et
al
bosch
et
al
shulla
et
al
yield
two
noncoval
associ
subunit
first
cleavag
event
along
bind
host
receptor
promot
cleavag
site
sarscov
belouzard
et
al
merscov
millet
whittak
park
et
al
proteolysi
conserv
site
essenti
fusion
activ
character
cov
protein
occur
host
membran
intern
cellular
compart
target
cell
belouzard
et
al
burkard
et
al
millet
whittak
park
et
al
cleavag
merscov
site
furin
viral
egress
enabl
subsequ
exposur
site
upon
bind
host
receptor
second
cleavag
step
serin
proteas
anchor
membran
target
cell
eventu
lead
fusion
cytoplasm
membran
earli
entri
convers
merscov
bud
uncleav
glycoprotein
traffic
endosom
target
cell
cathepsin
l
proteas
promot
membran
fusion
late
entri
former
mechan
propos
rout
merscov
entri
cell
type
relev
lung
infect
therefor
signific
determin
merscov
virul
moreov
tetraspanin
implic
cluster
transmembran
serin
proteas
promot
earli
entri
merscov
earnest
et
al
earnest
et
al
pedv
replic
epitheli
cell
small
intestin
undergo
proteolyt
activ
trypsin
highli
abund
intestin
lumen
critic
import
cleavag
site
also
exemplifi
studi
merscovrel
bat
coronaviru
although
recogn
human
vitro
infect
assay
reveal
entri
human
cell
requir
addit
exogen
trypsin
suggest
proteolyt
activ
bat
viru
occur
human
cell
wang
et
al
line
find
variou
mammalian
orthologu
variabl
bind
affin
merscov
receptorbind
domain
shown
support
viru
pseudoviru
entri
target
cell
presenc
activ
proteas
barlan
et
al
result
collect
illustr
specif
proteolyt
cleavag
particip
determin
intracellular
site
fusion
also
viral
tropism
pathogenesi
cov
therefor
zoonot
potenti
cov
determin
receptor
engag
also
proteolyt
process
protein
requir
fusion
activ
show
vitro
trypsin
cleavag
mhv
sarscov
merscov
limit
proteolysi
condit
recapitul
fusion
activ
induc
preto
postfus
transit
wall
et
al
cryoem
structur
mhv
subunit
ectodomain
trimer
reveal
membran
fusion
involv
largescal
conform
chang
reminisc
one
describ
class
fusion
protein
includ
pneumovirusparamyxoviru
f
glycoprotein
fig
mclellan
et
al
swanson
et
al
swanson
et
al
wall
et
al
yin
et
al
experi
also
demonstr
subunit
stabil
fusion
machineri
springload
metast
prefus
state
initi
infect
ii
postfus
ground
state
fusion
reaction
similarli
organ
influenza
viru
hemagglutinin
xiong
et
al
domain
b
interact
helix
hairpin
prefus
close
structur
like
stabil
springload
prefus
state
interact
appear
coordin
receptor
engag
fusion
upon
receptor
bind
proteolyt
cleavag
site
crown
like
shed
observ
merscov
yuan
et
al
facilit
conform
chang
involv
project
fusion
peptid
distanc
insert
target
membran
fig
wall
et
al
wall
et
al
free
energi
releas
upon
refold
prefus
postfus
state
believ
bring
viral
host
membran
close
proxim
promot
membran
merger
harrison
recent
structur
work
compar
recombin
protein
sarscov
merscov
isol
complex
cognat
receptor
neutral
antibodi
suggest
activ
mechan
coronaviru
fusion
gui
et
al
kirchdoerf
et
al
song
et
al
wall
et
al
yuan
et
al
specif
sarscov
merscov
structur
complex
neutral
antibodi
isol
survivor
show
antibodi
competit
block
receptor
interact
agreement
previou
surfac
plasmon
reson
data
corti
et
al
rockx
et
al
traggiai
et
al
wall
et
al
antisarscov
antibodi
howev
function
mimick
receptor
promot
fusogen
conform
rearrang
molecular
ratchet
mechan
fig
observ
suggest
upon
receptor
recognit
bound
b
domain
lock
open
state
therebi
releas
constraint
impos
helix
hairpin
allow
refold
fusion
machineri
membran
fusion
occur
pallesen
et
al
song
et
al
wall
et
al
yuan
et
al
fig
proteolyt
activ
like
requir
ensur
glycoprotein
work
synergi
proper
spatial
tempor
coordin
drive
fusion
viral
host
membran
deep
knowledg
organ
chemic
composit
carbohydr
obstruct
surfac
cov
glycoprotein
key
understand
access
neutral
antibodi
guid
ration
develop
subunit
vaccin
therapeut
glycoprotein
featur
predict
nlink
oligosaccharid
per
protom
cryoem
structur
ectodomain
allow
visual
first
time
extens
nlink
glycan
cover
surfac
cov
trimer
wall
et
al
fig
subsequ
studi
reveal
numer
glycosyl
site
strictli
topolog
conserv
pdcov
although
two
glycoprotein
share
amino
acid
sequenc
ident
two
virus
belong
differ
genera
infect
differ
host
xiong
et
al
observ
suggest
cov
face
similar
immun
pressur
respect
host
area
mask
conserv
glycan
might
key
function
base
inform
gain
structur
glycan
particip
mask
receptorbind
loop
propos
glycan
shield
involv
immun
evas
similarli
wellcharacter
envelop
trimer
wall
et
al
comparison
nlink
oligosaccharid
fulllength
merscov
deriv
virion
produc
african
green
monkey
cell
purifi
merscov
ectodomain
recombinantli
produc
cell
reveal
extens
overlap
glycan
composit
includ
presenc
hybrid
complex
glycan
process
oligosaccharid
also
observ
decor
trimer
surfac
authent
sarscov
virion
krokhin
et
al
ritchi
et
al
data
indic
least
fraction
merscov
sarscov
virion
produc
cell
expos
glycanprocess
enzym
resid
golgi
apparatu
assembl
bud
contrast
previou
model
cov
bud
ng
et
al
stertz
et
al
common
featur
observ
glycosyl
pattern
glycoprotein
presenc
less
dens
glycosyl
region
surround
cleavag
site
conserv
fusion
peptid
near
cleavag
site
probabl
allow
access
activ
host
proteas
membran
fusion
take
place
wall
et
al
wall
et
al
fig
glycan
hole
could
target
epitopefocus
immunogen
design
new
therapeut
develop
cov
support
identif
neutral
epitop
within
compar
breach
envelop
glycan
shield
mccoy
et
al
recent
structur
function
character
cov
glycoprotein
provid
insight
mechan
use
virus
infect
host
cell
suggest
possibl
strategi
ration
design
vaccin
therapeut
introduc
stabil
mutat
prevent
prefus
postfus
transit
led
elicit
improv
neutral
titer
mice
key
tool
design
subunit
vaccin
cov
pallesen
et
al
furthermor
exposur
fusion
peptid
surfac
prefus
trimer
wall
et
al
conserv
among
cov
indic
might
attract
target
broad
inhibit
cov
entri
major
antigen
determin
mhv
sarscov
overlap
fusion
peptid
region
daniel
et
al
zhang
et
al
bind
neutral
antibodi
site
could
put
prevent
fusogen
conform
chang
propos
influenza
viru
hemagglutinin
hiv
envelop
corti
et
al
kong
et
al
lang
et
al
final
mask
strainspecif
antigen
region
via
engin
addit
nlink
glycosyl
site
implement
merscov
domain
b
du
et
al
bear
promis
focus
immun
respons
highli
conserv
epitop
elicit
broadli
neutral
antibodi
cov
